Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEB-TACE vs cTACE for HCC in Egyptian Patients
NCT03007225Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Jul 2015
- Primary completion
- Aug 2016
- Modality
- Transdermal Patches, Small Molecules
01
Overview
A Phase 4 trial of pegylated liposomal doxorubicin in hepatocellular carcinoma (HCC), sponsored by Ain Shams University. Started Jul 2015; status: completed.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03007225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03007225.